In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R56 AI156383
BLRD VA
Grant: IK6 BX005235
NIDDK NIH HHS
Grant: P30 DK123704
NIAID NIH HHS
Grant: U01 AI132894
NIAID NIH HHS
Grant: R56 AI119026
National Institutes of Health
Grant: 5U01AI132894-04
Graft-targeted anti-complement therapy to reduce cardiac graft injury and allograft vasculopathy
National Institutes of Health
Grant: 1R56AI156383-01
Brain death associated vascularized composite allograft injury and its impact on alloimmunity and functional recovery
U.S. Department of Defense
National Institutes of Health
FWCI
1.02
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals